Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Cardiol ; 170: 147-154, 2022 05 01.
Article in English | MEDLINE | ID: mdl-35260240

ABSTRACT

Acute type A aortic dissection requires timely diagnosis and intervention. Previous studies have examined risk factors associated with delayed diagnosis; however, the effect of socioeconomic status (SES) has not been previously studied. Our study examined the impact of various SES measures on time to diagnosis. We examined time to diagnosis in consecutive cases of acute type A aortic dissection at a single institution. SES variables included race/ethnicity, Medicaid eligibility, and residence in a zip code with an increased Distressed Communities Index-an aggregate measure of community SES. Delayed diagnosis was defined as time to diagnosis in the upper quartile of the study population (>6.6 hours). A model predicting risk factors for delayed diagnosis was created using multivariable logistic regression. Our study included 124 patients with a median time to diagnosis of 3.36 hours (interquartile range [IQR] 1.83 to 6.63). A total of 92 patients were in the nondelayed cohort (median diagnosis time of 2.59 hours, IQR 1.49 to 4.18) and 32 patients were in the delayed cohort (median diagnosis time of 15.57 hours, IQR 9.34 to 28.75). In multivariable logistic regression, residence in a high-Distressed Communities Index zip code was associated with diagnostic delay (adjusted odds ratio [aOR] 5.108, p = 0.008). Patient age (aOR 0.944, p = 0.011), chest pain at presentation (aOR 0.099, p = 0.004), back pain at presentation (aOR 0.247, p = 0.012), evidence of malperfusion syndrome (aOR 0.040, p <0.001), history of hyperlipidemia (aOR 3.507, p = 0.026), and history of congestive heart failure (aOR 0.061, p = 0.036) were also significantly associated. In conclusion, our findings suggest community-level SES affects time to diagnosis in acute type A aortic dissection.


Subject(s)
Aortic Dissection , Delayed Diagnosis , Aortic Dissection/diagnosis , Aortic Dissection/epidemiology , Humans , Odds Ratio , Retrospective Studies , Risk Factors , Social Class , Socioeconomic Factors
2.
Cardiol Rev ; 19(3): 101-7, 2011.
Article in English | MEDLINE | ID: mdl-21464637

ABSTRACT

The long-term benefits of a left internal mammary artery bypass graft compared to the left anterior descending artery have been well described. The use of drug-eluting stents has minimized the morbidity of revascularization. Hybrid coronary revascularization is the planned use of minimally invasive surgical techniques for left internal mammary artery-left anterior descending artery grafting and the use of percutaneous coronary intervention for nonleft anterior descending coronary artery target revascularization. The optimal timing and order of revascularization in hybrid coronary revascularization remains unclear.


Subject(s)
Coronary Artery Bypass/methods , Coronary Artery Disease/surgery , Internal Mammary-Coronary Artery Anastomosis/methods , Angioplasty, Balloon, Coronary , Coronary Artery Bypass/trends , Forecasting , Humans , Minimally Invasive Surgical Procedures
3.
Semin Thorac Cardiovasc Surg ; 21(3): 229-36, 2009.
Article in English | MEDLINE | ID: mdl-19942121

ABSTRACT

The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.


Subject(s)
Angioplasty, Balloon, Coronary/methods , Coronary Artery Disease/surgery , Internal Mammary-Coronary Artery Anastomosis/methods , Combined Modality Therapy , Drug-Eluting Stents , Humans , Minimally Invasive Surgical Procedures/methods , Randomized Controlled Trials as Topic , Robotics
SELECTION OF CITATIONS
SEARCH DETAIL
...